BCL2 and small cell lung carcinoma: Yet, we could not observe synergism with drugs that induce DNA damage (e.g., cisplatin, etoposide) and activate apoptosis through BCL-2 family members, possibly because the loss of P53 in SCLC alters the cellular response to DNA damage.